News & Updates

Be updated with the developments in incretin-based treatment for diabetes

[ Incretin Odyssey ]

Debunking the myths about DPP-4 inhibitors

Navigating the evolving landscape of diabetes management requires precise knowledge. In this exploration into the world of DPP-4 inhibitors (DPP4is), we aim to debunk prevalent myths and provide nuanced insights.

Revisiting the GIP hormone

[ Dr. Augusto Litonjua ]

Product Highlight - Dapagliflozin (Forxiga)

Film-Coated Tablet 10 mg

Product Highlight - Vericiguat (Verquvo)

Film-Coated Tablet 2.5 mg, 5 mg, and 10 mg

Product Highlight - Apixaban (Embolis 2.5/Embolis 5)

Film-Coated Tablet 2.5 mg and 5 mg

Product Highlight - Telmisartan, Amlodipine Besilate (Mistacor AM)

Tablet 40 mg/5 mg, 40 mg/10 mg, 80 mg/5 mg and 80 mg/10 mg

Robust evidence for fenofibrate in patients with metabolic syndrome on statins

Product Highlight -Mistacor AM

Telmisartan, amlodipine besilate 40 mg/5 mg, 40 mg/10 mg, 80 mg/5 mg and 80 mg/10 mg tablet

Gliclazide Diabetes Mellitus D